EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-world evidence on the CamAPS FX hybrid closed-loop system in people living with type 1 diabetes

Charlotte K. Boughton, Tomas Hovorka, Malgorzata E. Wilinska, Sara Hartnell, Roman Hovorka

Metabologia · 2026

DOI: 10.1007/s44357-025-00002-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabologia, 2026. Verfasst von Charlotte K. Boughton und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We analysed real-world data to evaluate the performance of the CamAPS FX hybrid closed-loop system I people living with type 1 diabetes.

Methods

Users from 19 countries across different age groups who used the system between 1 January 2024, and 31 December 2024, and who had ≥ 60 days of continuous glucose monitor data with ≥ 30% of closed-loop usage were included in the current analysis ( N = 35,714).

Results

Time in target glucose range (3.9–10 mmol/l) was median (IQR) 69.6% (61.3–77.2) for all users and varied across the different age groups from 62.5% (53.4–71.2) for young adult users aged 18–22 years old to 76.1% (68.9–82.4) for users aged ≥ 65 years. Median (IQR) time spent in hypoglycaemia (< 3.9 mmol/l) was 2.5% (1.4–3.9) overall, and was < 4% across all age groups. Mean glucose and glucose management indicator overall were 8.7 ± 1.2 mmol/l and 7.1 ± 0.5% (53.6 ± 5.8 mmol/mol), respectively. Median (IQR) time in closed-loop was high at 95.7% (92.9‒97.3).

Conclusions

This retrospective observational analysis of real-world data demonstrates the performance of the CamAPS FX hybrid closed-loop system with outcomes comparable to those reported from previous randomised controlled studies.

Zitieren

APA

Boughton, C. K., Hovorka, T., Wilinska, M. E., Hartnell, S., & Hovorka, R. (2026). Real-world evidence on the CamAPS FX hybrid closed-loop system in people living with type 1 diabetes. Metabologia. https://doi.org/10.1007/s44357-025-00002-2

Vancouver

Boughton CK, Hovorka T, Wilinska ME, Hartnell S, Hovorka R. Real-world evidence on the CamAPS FX hybrid closed-loop system in people living with type 1 diabetes. Metabologia. 2026. doi:10.1007/s44357-025-00002-2

BibTeX
@article{Boughton2026,
  author = {Boughton, Charlotte K. and Hovorka, Tomas and Wilinska, Malgorzata E. and Hartnell, Sara and Hovorka, Roman},
  title = {Real-world evidence on the CamAPS FX hybrid closed-loop system in people living with type 1 diabetes},
  journal = {Metabologia},
  year = {2026},
  doi = {10.1007/s44357-025-00002-2}
}
Kostenlos starten →